Evidence map›Paper›PMID 38887977›Full record

ArticleJournal of cellular and molecular medicine2024

Unravelling the role of PLK1 in tumorigenesis by revealing the mutational landscape of colorectal and lung cancer with PLK1 mutations.

Shuo Wang, Feng Gao, Yinghui Bi, Xiaotian Zhao, Qiuxiang Ou, Minyi Zhu, Xue Wu, Xuefei Zhang, Kaiping Mao

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of cellular and molecular medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Shuo WangKey laboratory of Carcinogenesis and Translational Research (Ministry of Education), Urological Department, Peking University Cancer Hospital & Institute, Beijing, China.
Feng GaoDepartment of Medical Oncology, Beidahuang Industry Group General Hospital, Harbin, China.
Yinghui BiDepartment of Oncology, Qingdao Hospital, University of Health and Rehabilitation Sciences (Qingdao Municipal Hospital), Qingdao, China.
Xiaotian ZhaoGeneseeq Research Institute, Nanjing Geneseeq Technology Inc., Nanjing, China.ORCID 0000-0003-3823-3232
Qiuxiang OuGeneseeq Research Institute, Nanjing Geneseeq Technology Inc., Nanjing, China.
Minyi ZhuGeneseeq Research Institute, Nanjing Geneseeq Technology Inc., Nanjing, China.
Xue WuGeneseeq Research Institute, Nanjing Geneseeq Technology Inc., Nanjing, China.
Xuefei ZhangDepartment of Thoracic Surgery I, The Second Hospital of Dalian Medical University, Dalian, China.
Kaiping MaoDepartment of Thoracic Surgery, The Affiliated Hospital of Qingdao University, Qingdao, China.ORCID 0009-0000-9549-6886

Funding

"1+X" program for Clinical Competency Enhancement-Clinical Research Incubation Project, the Second Hospital of Dalian Medical University 2022LCYJYB09Science foundation of Peking University Cancer Hospital 2021-7Special Fund for Clinical Research of Wu Jieping Medical Foundation 320.6750.2021-16-8
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CarcinogenesisCell Cycle ProteinsColorectal NeoplasmsLung NeoplasmsMutationPolo-Like Kinase 1Protein Serine-Threonine KinasesProto-Oncogene ProteinsHumansCell Cycle ProteinsPolo-Like Kinase 1Protein Serine-Threonine KinasesProto-Oncogene Proteinscolorectal cancerlung cancermutational landscapePLK1tumour‐suppressor feature

Identifiers

PMID38887977
PMCPMC11184281

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.